31 October 2022>: Clinical Research
hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis
Hanjiang Xu 123BCDEF , Meng Zhang 123BCDEF , Zongyao Hao 123AC , Chaozhao Liang 123A*DOI: 10.12659/MSM.938012
Med Sci Monit 2022; 28:e938012
Figure 1 Flowchart of our meta-analysis study. (PowerPoint, v2020, Microsoft Co. Ltd.).